“DOXORUBICIN’S ROLE IN CANCER TREATMENT AND ITS SIDE EFFECTS ON HUMAN HEALTH”, Aca. Glo. Ind.Res., vol. 3, no. 11, pp. 165–183, Dec. 2022, doi: 10.17605/OSF.IO/EC5AS.